Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinial Trials

- PMLiVE

Sanofi Genzyme launches multiple sclerosis awareness campaign

Aims to highlight and address the physical and emotional burden of the disease

First things first: How to kick-off an e-detailing project

Starting a new e-detailing project? Here are our tips to set a solid base for it

Anthill Agency

EU flag

Imbruvica wins wider European leukaemia licence

AbbVie and J&J’s first-in-class drug now approved to treat all CLL patients in the EU

Daiichi Sankyo logo

Daiichi pulls study of patritumab in lung cancer

HER3 inhibitor candidate showed no evidence of efficacy in trial analysis

Biogen Idec building

Biogen and AbbVie bag FDA approval for multiple sclerosis drug

Once-monthly, self-administered Zinbryta ‘significantly’ reduces relapse rate

- PMLiVE

Improving patient outcomes, recognising excellence

Medical education is expanding beyond message delivery into demonstrating that the education actually improves patient outcomes, says Lucid’s Jan Steele

Teva Pharma logo

FDA turns down Teva’s Huntington’s disease drug

Has requested further analysis on certain metabolites of the chorea candidate

- PMLiVE

Caldan Therapeutics bolsters senior team

Dr Frank Armstrong, Dr Philip Boyd, Dr Gerry Thomas and Dr Stephen Connolly join

Digital communications—not just for whitespace anymore

By Brad Davidson, PhD, SVP Strategic Planning

Aptus Health

PEGASUS JOINS ASHFIELD HEALTHCARE COMMUNICATIONS

Pegasus, one of the most successful integrated healthcare communications consultancies in the UK, has today announced it has been acquired by UDG Healthcare plc, a FTSE 250 listed international provider...

Inizio

Legal developments in product liability

With restrictive legislation and recent landmark cases, the medical industry is under increasing legal pressure

Gilead Sciences

Gilead, Merck get CHMP backing for new hep C combinations

Approval of Epclusa and Zepatier will see the pan-genotypic drugs compete for market share

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links